Kringle Pharma, Inc.(JP:4884)
Â¥521.00+2.00 (+0.39%)
JP:4884
Kringle Pharma, Inc. Revenue
Â¥521.00
At close:+2.00 (+0.39%)
Want to see JP:4884 full AI Analyst Report?
Kringle Pharma, Inc. (4884) Revenue
0 Followers
Kringle Pharma, Inc. Revenue
Kringle Pharma, Inc. had a revenue of 287.15M in the quarter ending Jun 30, 2026, with 1547.46%. This bring the company's revenue in the last twelve months to 341.47M, Increased 372.39%. In the fiscal year ending Sep 30, 2025, Kringle Pharma, Inc. had annual revenue of 72.22M with -9.77% growth.
- Revenue (ttm)
- 341.47M
- Revenue Growth
- 513.34%
- P/S Ratio
- 61.76
- Revenue/Employee
- JPY 4,247,941
- Employees
- 17
- Market Cap
- JPY 4.46B
Revenue Chart
Kringle Pharma, Inc. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 72.22M | -7.82M | -9.77% |
| Sep 30, 2024 | 80.04M | 10.79M | 15.58% |
| Sep 30, 2023 | 69.25M | -322.58M | -82.33% |
| Sep 30, 2022 | 391.83M | 102.07M | 35.23% |
| Sep 30, 2021 | 289.76M | -177.86M | -38.04% |
| Sep 30, 2020 | 467.62M | 467.62M | ― |
| Sep 30, 2019 | 0.00 | 0.00 | ― |
| Sep 30, 2018 | 0.00 | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.